|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - HEMISPHERX BIOPHARMA INC (HEB)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-11-30 Purchase |
2018-12-03 11:32 am |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
20,000 | $0.1922 | $3,845 | 798,307 (Direct) |
View |
| 2018-11-05 Purchase |
2018-11-06 11:24 am |
HEMISPHERX BIOPHARMA INC | HEB | APPELROUTH STEWART Director |
25,238 | $0.22 | $5,552 | 266,988 (Direct) |
View |
| 2018-10-26 Purchase |
2018-10-29 09:14 am |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
3,500 | $0.203 | $710 | 775,807 (Direct) |
View |
| 2018-10-25 Purchase |
2018-10-25 09:22 am |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
100,000 | $0.2 | $20,000 | 772,307 (Direct) |
View |
| 2018-07-27 Purchase |
2018-07-27 09:31 am |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
34,483 | $0.29 | $10,000 | 672,306 (Direct) |
View |
| 2018-07-24 Purchase |
2018-07-24 09:24 am |
HEMISPHERX BIOPHARMA INC | HEB | APPELROUTH STEWART Director |
126,000 | $0.31 | $39,060 | 241,750 (Direct) |
View |
| 2018-07-23 Purchase |
2018-07-23 10:49 am |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
112,904 | $0.31 | $35,000 | 637,823 (Direct) |
View |
| 2018-07-23 Purchase |
2018-07-23 10:06 am |
HEMISPHERX BIOPHARMA INC | HEB | SPRINGATE WAYNE S VP |
32,259 | $0.31 | $10,000 | 64,773 (Direct) |
View |
| 2018-07-23 Purchase |
2018-07-23 09:32 am |
HEMISPHERX BIOPHARMA INC | HEB | PASCALE ADAM CFO |
32,259 | $0.31 | $10,000 | 59,648 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-01-28 Option Award |
2019-01-30 12:35 pm |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | APPELROUTH STEWART Director |
207,343 | $0.22 | 207,343 (Direct) |
View |
| 2019-01-28 Option Award |
2019-01-30 12:35 pm |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | APPELROUTH STEWART Director |
50,000 | $0.22 | 207,343 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-30 12:12 pm |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | MITCHELL WILLIAM M Director |
207,343 | $0.22 | 207,343 (Direct) |
View |
| 2019-01-30 Option Award |
2019-01-30 12:12 pm |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | MITCHELL WILLIAM M Director |
50,000 | $0.22 | 207,343 (Direct) |
View |
| 2019-01-28 Option Award |
2019-01-30 11:36 am |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | STRAYER DAVID R Chief Science/Medical Officer |
184,659 | $0.22 | 184,659 (Direct) |
View |
| 2019-01-28 Option Award |
2019-01-30 11:24 am |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | RODINO III PETER W. Dir Govt Relations/Sectry |
198,864 | $0.22 | 198,864 (Direct) |
View |
| 2019-01-28 Option Award |
2019-01-30 10:59 am |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | PASCALE ADAM CFO |
142,046 | $0.22 | 142,046 (Direct) |
View |
| 2019-01-28 Option Award |
2019-01-30 10:46 am |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | SPRINGATE WAYNE S VP |
142,046 | $0.22 | 142,046 (Direct) |
View |
| 2019-01-28 Option Award |
2019-01-30 10:20 am |
2019-01-28 2029-01-28 |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
426,136 | $0.22 | 426,136 (Direct) |
View |
| 2018-11-27 Option Award |
2018-11-29 12:16 pm |
N/A N/A |
HEMISPHERX BIOPHARMA INC | HEB | MITCHELL WILLIAM M Director |
2,500 | $0 | 11,197 (Direct) |
View |
| 2018-11-27 Option Award |
2018-11-29 11:27 am |
N/A N/A |
HEMISPHERX BIOPHARMA INC | HEB | APPELROUTH STEWART Director |
2,500 | $0 | 269,488 (Direct) |
View |
| 2018-11-27 Option Award |
2018-11-29 11:05 am |
N/A N/A |
HEMISPHERX BIOPHARMA INC | HEB | RODINO III PETER W. Dir Govt Relations/Sectry |
2,500 | $0 | 18,373 (Direct) |
View |
| 2018-11-27 Option Award |
2018-11-29 10:34 am |
N/A N/A |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
2,500 | $0 | 778,307 (Direct) |
View |
| 2018-11-27 Option Award |
2018-11-29 10:11 am |
N/A N/A |
HEMISPHERX BIOPHARMA INC | HEB | STRAYER DAVID R Chief Science/Medical Officer |
2,500 | $0 | 44,304 (Direct) |
View |
| 2018-11-27 Option Award |
2018-11-29 09:42 am |
N/A N/A |
HEMISPHERX BIOPHARMA INC | HEB | SPRINGATE WAYNE S VP |
2,500 | $0 | 67,273 (Direct) |
View |
| 2018-11-27 Option Award |
2018-11-29 09:20 am |
N/A N/A |
HEMISPHERX BIOPHARMA INC | HEB | PASCALE ADAM CFO |
2,500 | $0 | 62,148 (Direct) |
View |
| 2018-11-14 Option Award |
2018-11-16 12:16 pm |
2018-11-14 2028-11-14 |
HEMISPHERX BIOPHARMA INC | HEB | RODINO III PETER W. Dir Govt Relations/Sectry |
1,000 | $0.22 | 1,000 (Direct) |
View |
| 2018-11-14 Option Award |
2018-11-16 11:55 am |
2018-11-14 2028-11-14 |
HEMISPHERX BIOPHARMA INC | HEB | STRAYER DAVID R Chief Science/Medical Officer |
1,000 | $0.22 | 1,000 (Direct) |
View |
| 2018-11-14 Option Award |
2018-11-16 11:38 am |
2018-11-14 2028-11-14 |
HEMISPHERX BIOPHARMA INC | HEB | SPRINGATE WAYNE S VP |
1,000 | $0.22 | 1,000 (Direct) |
View |
| 2018-11-14 Option Award |
2018-11-16 11:22 am |
2018-11-14 2028-11-14 |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
1,000 | $0.22 | 1,000 (Direct) |
View |
| 2018-11-14 Option Award |
2018-11-16 10:55 am |
2018-11-14 2028-11-14 |
HEMISPHERX BIOPHARMA INC | HEB | PASCALE ADAM CFO |
1,000 | $0.22 | 1,000 (Direct) |
View |
| 2018-10-17 Option Award |
2018-10-19 1:12 pm |
2018-10-17 2028-10-17 |
HEMISPHERX BIOPHARMA INC | HEB | APPELROUTH STEWART Director |
172,786 | $0.22 | 172,786 (Direct) |
View |
| 2018-10-17 Option Award |
2018-10-19 1:00 pm |
2018-10-17 2028-10-17 |
HEMISPHERX BIOPHARMA INC | HEB | MITCHELL WILLIAM M Director |
172,786 | $0.22 | 172,786 (Direct) |
View |
| 2018-10-17 Option Award |
2018-10-19 12:46 pm |
2018-10-17 2028-10-17 |
HEMISPHERX BIOPHARMA INC | HEB | RODINO III PETER W. Dir Govt Relations/Sectry |
132,576 | $0.22 | 132,576 (Direct) |
View |
| 2018-10-17 Option Award |
2018-10-19 12:31 pm |
2018-10-17 2028-10-17 |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
284,091 | $0.22 | 284,091 (Direct) |
View |
| 2018-10-17 Option Award |
2018-10-19 12:08 pm |
2018-10-17 2028-10-17 |
HEMISPHERX BIOPHARMA INC | HEB | SPRINGATE WAYNE S VP |
94,697 | $0.22 | 94,697 (Direct) |
View |
| 2018-10-17 Option Award |
2018-10-19 11:24 am |
2018-10-17 2028-10-17 |
HEMISPHERX BIOPHARMA INC | HEB | STRAYER DAVID R Chief Science/Medical Officer |
123,106 | $0.22 | 123,106 (Direct) |
View |
| 2018-10-17 Option Award |
2018-10-19 10:57 am |
2018-10-17 2028-10-17 |
HEMISPHERX BIOPHARMA INC | HEB | PASCALE ADAM CFO |
94,697 | $0.22 | 94,697 (Direct) |
View |
| 2018-07-18 Option Award |
2018-07-20 10:48 am |
2018-07-18 2028-07-18 |
HEMISPHERX BIOPHARMA INC | HEB | APPELROUTH STEWART Director |
98,098 | $0.31 | 98,098 (Direct) |
View |
| 2018-07-18 Option Award |
2018-07-20 10:11 am |
2018-07-18 2028-07-18 |
HEMISPHERX BIOPHARMA INC | HEB | MITCHELL WILLIAM M Director |
98,098 | $0.31 | 98,098 (Direct) |
View |
| 2018-07-18 Option Award |
2018-07-19 2:41 pm |
2018-07-18 2028-07-18 |
HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO |
161,290 | $0.31 | 161,290 (Direct) |
View |
| 2018-07-18 Option Award |
2018-07-19 1:50 pm |
2018-07-18 2028-07-18 |
HEMISPHERX BIOPHARMA INC | HEB | RODINO III PETER W. Dir Govt Relations/Sectry |
75,269 | $0.31 | 75,269 (Direct) |
View |
| 2018-07-18 Option Award |
2018-07-19 12:50 pm |
2018-07-18 2028-07-18 |
HEMISPHERX BIOPHARMA INC | HEB | PASCALE ADAM CFO |
53,763 | $0.31 | 53,763 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Fri, 22 Feb 2019 20:52:32 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |